The Model for Early COvid-19 Recognition (MECOR) Score: A Proof-of-Concept for a Simple and Low-Cost Tool to Recognize a Possible Viral Etiology in Community-Acquired Pneumonia Patients during COVID-19 Outbreak

This study aims to assess the peripheral blood cell count “signature” of Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2) to discriminate promptly between COronaVIrus Disease 19 (COVID-19) and community-acquired pneumonia (CAP). We designed a retrospective case-control study, enrolling 525 patients (283 COVID-19 and 242 with CAP). All patients had a fever and at least one of the following signs: cough, chest pain, or dyspnea. We excluded patients treated with immunosuppressants, steroids, or affected by diseases known to modify blood cell count. COVID-19 patients showed a significant reduction in white blood cells (neutrophils, lymphocytes, monocytes, eosinophils) and platelets. We studied these parameters univariately, combined the significant ones in a multivariate model (AUROC 0.86, Nagelkerke PSEUDO-R2 0.5, Hosmer–Lemeshow p-value 0.9) and examined its discriminative performance in an internally-randomized validation cohort (AUROC 0.84). The cut-off selected according to Youden’s Index (−0.13) showed a sensitivity of 84% and a specificity of 72% in the training cohort, and a sensitivity of 88% and a specificity of 73% in the validation cohort. In addition, we determined the probability of having COVID-19 pneumonia for each Model for possible Early COvid-19 Recognition (MECOR) Score value. In conclusion, our model could provide a simple, rapid, and cheap tool for prompt COVID-19 diagnostic triage in patients with CAP. The actual effectiveness should be evaluated in further, prospective studies also involving COVID-19 patients with negative nasopharyngeal swabs.

[1]  Hongming Miao,et al.  Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study , 2020, Signal transduction and targeted therapy.

[2]  Jun Zhang,et al.  Patients of COVID-19 may benefit from sustained Lopinavir-combined regimen and the increase of Eosinophil may predict the outcome of COVID-19 progression , 2020, International Journal of Infectious Diseases.

[3]  L. Boon,et al.  Eosinophil differentiation in the bone marrow is inhibited by T cell-derived IFN-gamma. , 2010, Blood.

[4]  Chi-kong Li,et al.  Thrombocytopenia in patients with severe acute respiratory syndrome (review) , 2005, Hematology.

[5]  Michel Theron,et al.  An interferon‐γ‐related cytokine storm in SARS patients† , 2004, Journal of medical virology.

[6]  R. Woods,et al.  Neutrophil extracellular traps in COVID-19. , 2020, JCI insight.

[7]  Z. Fayad,et al.  Artificial intelligence–enabled rapid diagnosis of patients with COVID-19 , 2020, Nature Medicine.

[8]  T. Güngör,et al.  Two new inflammatory markers associated with Disease Activity Score‐28 in patients with rheumatoid arthritis: neutrophil‐lymphocyte ratio and platelet‐lymphocyte ratio , 2015, International journal of rheumatic diseases.

[9]  S. Lofgren,et al.  Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 , 2020, Annals of Internal Medicine.

[10]  Jian-Ping Liu,et al.  The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients , 2020, International Immunopharmacology.

[11]  G. Zini,et al.  Morphological anomalies of circulating blood cells in COVID‐19 , 2020, American journal of hematology.

[12]  Depei Wu,et al.  The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China , 2020, Thrombosis Research.

[13]  Daniel B. Mark,et al.  TUTORIAL IN BIOSTATISTICS MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORS , 1996 .

[14]  A. Pulvirenti,et al.  Neutrophil-to-Lymphocyte Ratio is a strong predictor of atherosclerotic carotid plaques in older adults. , 2018, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[15]  H. Ullum,et al.  The neutrophil-to-lymphocyte ratio is associated with multiple sclerosis , 2018, Multiple sclerosis journal - experimental, translational and clinical.

[16]  C. Akdis,et al.  Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China , 2020, Allergy.

[17]  Lei Liu,et al.  Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infections , 2020, medRxiv.

[18]  G. Bedogni,et al.  Spleen Stiffness Probability Index (SSPI): A simple and accurate method to detect esophageal varices in patients with compensated liver cirrhosis. , 2019, Annals of hepatology.

[19]  W. Self,et al.  Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults. , 2015, The New England journal of medicine.

[20]  R. Caporali,et al.  Novel COronaVirus Disease 2019 (COVID-19) epidemic: What are the risks for systemic sclerosis patients? , 2020, Autoimmunity Reviews.

[21]  W. Ko,et al.  Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths , 2020, Journal of Microbiology, Immunology and Infection.

[22]  A. Ateş,et al.  Association of simple hematological parameters with disease manifestations, activity, and severity in patients with systemic sclerosis , 2019, Clinical Rheumatology.

[23]  F. Harrell,et al.  Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .

[24]  A. Addeo,et al.  Neutrophil-to-lymphocyte ratio and lactate dehydrogenase as biomarkers for urothelial cancer treated with immunotherapy , 2020, Clinical and Translational Oncology.

[25]  Xiaohu Zheng,et al.  Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients , 2020, National science review.

[26]  J. Hanley,et al.  The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.

[27]  Michael J Pencina,et al.  Novel metrics for evaluating improvement in discrimination: net reclassification and integrated discrimination improvement for normal variables and nested models , 2012, Statistics in medicine.

[28]  Wei Zhang,et al.  Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes , 2020, Emerging microbes & infections.

[29]  W. Youden,et al.  Index for rating diagnostic tests , 1950, Cancer.

[30]  Steven Woloshin,et al.  False Negative Tests for SARS-CoV-2 Infection - Challenges and Implications. , 2020, The New England journal of medicine.

[31]  M. Nolte,et al.  Impact of Viral Infections on Hematopoiesis: From Beneficial to Detrimental Effects on Bone Marrow Output , 2016, Front. Immunol..

[32]  Peter Rogerson,et al.  Statistical methods for geography , 2001 .

[33]  T. van der Poll,et al.  The Neutrophil-Lymphocyte Count Ratio in Patients with Community-Acquired Pneumonia , 2012, PloS one.

[34]  A. Pulvirenti,et al.  Neutrophil‐To‐Lymphocyte Ratio: An Emerging Marker Predicting Prognosis in Elderly Adults with Community‐Acquired Pneumonia , 2017, Journal of the American Geriatrics Society.

[35]  P. Winichakoon,et al.  Negative Nasopharyngeal and Oropharyngeal Swabs Do Not Rule Out COVID-19 , 2020, Journal of Clinical Microbiology.

[36]  Binqing Fu,et al.  Why tocilizumab could be an effective treatment for severe COVID-19? , 2020, Journal of Translational Medicine.